. Thorax, 33,. Reproducibility and comparison of responses to inhaled histamine and methacholine. The efficiency of a standardised inhalation test procedure was studied by examining the reproducibility of responses to histamine and methacholine. In addition, the responses to the two agents were compared. Each set of duplicate tests was carried out on a separate day within one week, and all factors known or presumed to influence responses were carefully controlled. The results were expressed as the provocative concentration of the agent causing a 20% fall in forced expired volume in one second (PC20). Responses to histamine and methacholine were highly reproducible (coefficients of determination [r2] = 0 994 and 0 990 respectively).
There was a small but significant cumulative dose effect with methacholine (P<0 01) but not with histamine. Side effects of throat irritation, flushing, and headache were more frequent with histamine than methacholine, and were dose-related. The high level of reproducibility indicates the efficiency of the test procedure. The similar severity of effects by agents with different mnechanisms of action suggests that the primary cause of non-specific bronchial hyperreactivity lies at the level of bronchial smooth muscle.
Non-specific bronchial reactivity is the term used to indicate the responsiveness of the airways to chemical mediators, such as histamine, acetylcholine, and prostaglandin F2a, or to the synthetic analogues of acetylcholine, such as methacholine and carbachol. Its measurement is becoming increasingly important in clinical practice, epidemiology, and research.
Non-specific bronchial reactivity is measured by inhalation tests, usually with histamine or methacholine. In the past different methods have been used, making critical analysis of results difficult. Recently Chai et al (1975) and Orehek and Gayrard (1976) have emphasised the importance of the standardisation of tests. Standardisation requires consideration of the many different factors that will influence the results.
In this study we have standardised a simple inhalation test using histamine and methacholine. We have investigated the efficiency of the method by examining the reproducibility of responses over a short period. In addition we have compared the responsiveness to each agent and investigated the possibility of cumulative dose-effects and recorded side effects.
Subjects and methods

SUBJECTS
The patients were adults with asthma attending the regional chest and allergy unit. All had episodic dyspnoea or wheezing and documented variation in forced expired volume in one second (FEV1) of more than 20%, either spontaneously or after medication. None had features of any other respiratory disorder.
Normal adults were volunteers from hospital staff. They had no present or past symptoms of rhinitis, asthma, or other respiratory disorder. They were non-smokers, non-atopic, and had normal spirometry. Non-atopic implied that they had no early wheal and flare responses to prick tests with extracts of Alternaria, Cladosporium, E F Juniper, P A Frith, C Dunnett, D W Cockeroft, and F E Hargreave ragweed pollen. Informed signed consent was obtained.
INHALATION TESTS
Inhalation tests were carried out by the method described for histamine by Cockcroft et al (1977a) . Aerosols of physiological saline, histamine acid phosphate or methacholine were delivered into a face mask from a Wright nebuliser with an output of 0-13 ml/min and aerosol particles of 1-3 ,um mass median diameter and 2 11 ,um geometric standard deviation. A clip was placed on the nose and each aerosol was inhaled through the mouth by tidal breathing for 2 min. Physiological saline was inhaled first, followed at 5-min intervals by histamine or methacholine in twofold increasing concentrations from 003 to 16 mg/ml. The histamine solutions were made up as needed at intervals up to three months; methacholine solutions were renewed every two weeks.
The FEV1 was measured using a The short-term reproducibility of responses to histamine and to methacholine were investigated by performing two identical inhalation tests with each agent. Fourteen subjects (11 asthmatic, three normal) were tested with histamine, and another group of 13 subjects (11 asthmatic, two normal) were tested with methacholine.
Response to histamine and methacholine were compared in 33 asthmatic and 14 normal subjects by performing one identical test with each agent. Twenty-three of these subjects, with a PC20 of 1 mg/ml or above, completed a questionnaire regarding side effects after each test. The possibility of a cumulative dose effect produced by the method was examined for histamine in 15 subjects (14 asthmatics, one normal) and for methacholine in a different group of 10 subjects (eight asthmatic, two normal). 2) .
Inhalation of at least three doubling concentrations of methacholine at intervals of 5 min produced a small cumulative effect in every subject (fig 3a) . For the group this was a significant effect (P<001). By contrast, no cumulative effect was seen with histamine ( fig 3b) . Dyspnoea, chest tightness, or wheezing occurred with equal frequency after both agents in association with the fall in FEV1. Irritation of the throat and cough occurred alone or in association with headache or flushing more often with histamine than with methacholine; they were dose related (fig 4) . Among those subjects with "irritant" and systemic symptoms, seven had a fall in FEV1 of less than 20% after inhalation of histamine 8 mg/ ml. These seven were unable to tolerate histamine at 16 mg/ml but were able to tolerate methacholine up to 16 mg/ml, allowing falls in FEVY of greater than 20% to occur. (1) (Mercer, 1973) ; particle size also varies between nebulisers, although between 1 3 jum and 3 6 ,um it does not influence the response (Dolovich et al, 1978) . The method of inhalation influences the dose reaching the lung and the pattern of deposition in the lung (Pavia et al, 1977) . In the present study tidal breathing was used in preference to vital capacity inspirations because the latter influence lung mechanics (Gayrard et al, 1975; and produce more variability in lung dose and deposition pattern unless the speed of inspiration is carefully controlled (Pavia et al, 1977) . Other "non-technical" factors that may influence the response and which were controlled include time of day (deVries et al, 1962) , degree of initial airflow obstruction (Benson, 1975) , respiratory infection (Empey et al, 1976) vaccination (Ouellette and Read, 1965) , allergen exposure (Altounyan, 1971; Cockcroft et al, 1977b) , smoking, and medications (Chai et al, 1975; Cockcroft et al, 1977c ological, and research studies. For example, it may be used to diagnose the presence of asthma (Cockcroft et al, 1977a) , to examine the effect of medications (Cockcroft et al, 1977c) , to help predict long-term medication requirements (Cockcroft et al, 1977a) , to provide an index of risk to nonspecific stimuli in the environment , to help predict the dose of allergen that will trigger asthma (Killian et al, 1976; , to determine the specificity of responses to simple chemicals when antibodies cannot be shown (Vallieres et al, 1977) , and to explore mechanisms of hyperreactivity (Ouellette and Reed, 1965; Casterline et al, 1976; Empey et al, 1976; Casterline and Evans, 1977; Cockcroft et al, 1977b; Miller et al, 1977 , Frith et al, 1978 Ruffin et al, 1978 ). The present study shows a close correlation between bronchial responsiveness to histamine and methacholine. This close correlation indicates that the agents are equally effective in measuring the level of non-specific bronchial reactivity. The similarity in responsiveness also has implications in understanding the cause of the non-specific bronchial hyperreactivity of asthma, which at present remains unknown. One hypothesis is that there is a heightened sensitivity of irritant receptors and a consequent exaggerated reflex cholinergic bronchoconstriction (Nadel, 1977 (Casterline et al, 1976; Casterline and Evans, 1977; Ruffin et al, 1978) and H2 receptors (Frith et al, 1978) . By contrast methacholine is considered to have no effect on irritant receptors and to exert its effect through cholinergic receptors on smooth muscle (Goodman and Gilman, 1975; Miller et al, 1976) . In the present study the similar severity of effects by agents with different mechanisms of action suggests that the primary cause of the hyperreactivity lies at the level of smooth muscle. Such an alternative hypothesis has already been suggested by Antonissen et al (1977) and Miller et al (1978) .
In the present study inhalation of methacholine at 5-min intervals produced a cumulative effect, which was not seen with histamine. Histamine, however, produced more "irritant" and systemic side effects at higher doses. These differences between the effects of histamine and methacholine, which have been observed by others (Orehek and Gayrard, 1976) , need to be taken into account when considering which agent to use in studies of non-specific reactivity. Other possible differences between the agents include the shelf life and the degree of change in reactivity after allergen exposure. The shelf life is not accurately known, but is probably longer for histamine (years) than methacholine (weeks) (Windholz, 1976) . Changes in responsiveness to histamine after allergeninduced asthma are greater than changes in responsiveness to methacholine (Cockcroft et al, 1977b ). The present study shows, however, that when factors that modify responses are controlled, either agent may be used with equal efficiency to show the level of non-specific bronchial reactivity.
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